Show simple item record

dc.contributor.authorEmiroglu, NAZAN
dc.contributor.authorCengiz, FATMA PELİN
dc.contributor.authorERDEM, Gul Bahar
dc.date.accessioned2020-10-29T14:39:28Z
dc.date.available2020-10-29T14:39:28Z
dc.date.issued2015-01-01T00:00:00Z
dc.identifier.citationEmiroglu N., Cengiz F. P. , ERDEM G. B. , -Serum IL-17A in Behcet-s disease-, POSTEPY DERMATOLOGII I ALERGOLOGII, cilt.32, ss.358-361, 2015
dc.identifier.urihttp://hdl.handle.net/20.500.12645/25359
dc.identifier.urihttps://www.termedia.pl/Serum-IL-17A-in-Behcet-s-disease,7,25937,0,1.html
dc.description.abstractIntroduction: Behcet-s disease is a chronic multisystem disease with spontaneous remissions and relapses. Several studies show that autoimmune mechanisms play an important role in the development of Behcet-s disease. Activation of T cells and neutrophils is important in the pathogenesis of the disease. Interleukin 17 (IL-17) is a new cytokine that induces several types of cells to secrete proinflammatory cytokines in many inflammatory and autoimmune diseases.
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectBehcet-s disease
dc.titleSerum IL-17A in Behcet-s disease
dc.typeArticle
dc.identifier.wosWOS:000365404500007
dc.identifier.scopus84946012432
dc.identifier.doi10.5114/pdia.2015.54745
dc.identifier.pubmed26759544
local.publication.isinternational1


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record